Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited appears in FDA public data with 1 recall, 0 510(k) clearances, 13 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0164-2017, Class II) was initiated on September 9, 2016.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 13
- Compliance Actions
- 1
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0164-2017 | Class II | Ondansetron HCI API, Bulk, Manufacturer: Cadila Pharmaceuticals, Ltd., Ankleshwar, Gujarat, India 39 | September 9, 2016 |